Veracyte, Inc. (VCYT) Earnings History
Annual and quarterly earnings data from 2011 to 2025
Loading earnings history...
VCYT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
VCYT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 69.6% | 14.3% | 12.8% |
| 2024 | 66.9% | 3.6% | 5.4% |
| 2023 | 68.7% | -23.8% | -20.6% |
| 2022 | 65.7% | -13.9% | -12.3% |
| 2021 | 66.1% | -37.3% | -34.4% |
Download Data
Export VCYT earnings history in CSV or JSON format
Free sign-in required to download data
Veracyte, Inc. (VCYT) Earnings Overview
As of May 8, 2026, Veracyte, Inc. (VCYT) reported trailing twelve-month net income of $88M, reflecting +164.5% year-over-year growth. The company earned $1.08 per diluted share over the past four quarters, with a net profit margin of 12.8%.
Looking at the long-term picture, VCYT's historical earnings data spans multiple years. The company achieved its highest annual net income of $66M in fiscal 2025, representing a new all-time high.
Veracyte, Inc. maintains positive profitability with a gross margin of 69.6%, operating margin of 14.3%, and net margin of 12.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), NTRA (-$208M net income, -9.0% margin), CDNA (-$8M net income, -5.6% margin), VCYT has outperformed on profitability metrics. Compare VCYT vs EXAS →
VCYT Earnings vs Peers
Earnings metrics vs comparable public companies
VCYT Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $66M | +174.9% | $74M | $0.82 | 12.8% | 14.3% |
| 2024 | $24M | +132.4% | $16M | $0.31 | 5.4% | 3.6% |
| 2023 | -$74M | -103.5% | -$86M | $-1.02 | -20.6% | -23.8% |
| 2022 | -$37M | +51.6% | -$41M | $-0.51 | -12.3% | -13.9% |
| 2021 | -$76M | -116.5% | -$82M | $-1.11 | -34.4% | -37.3% |
| 2020 | -$35M | -177.1% | -$35M | $-0.66 | -29.7% | -30.1% |
| 2019 | -$13M | +45.2% | -$15M | $-0.27 | -10.5% | -12.6% |
| 2018 | -$23M | +25.8% | -$22M | $-0.62 | -25.0% | -24.2% |
| 2017 | -$31M | +1.1% | -$27M | $-0.91 | -43.1% | -36.9% |
| 2016 | -$31M | +7.0% | -$29M | $-1.09 | -48.2% | -44.3% |
See VCYT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VCYT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VCYT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVCYT — Frequently Asked Questions
Quick answers to the most common questions about buying VCYT stock.
Is VCYT growing earnings?
VCYT EPS is $1.08, with earnings growth accelerating to +164.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $88M.
What are VCYT's profit margins?
Veracyte, Inc. net margin is +12.8%, with operating margin at +14.3%. Margins sit within typical range for the sector.
How consistent are VCYT's earnings?
VCYT earnings data spans 2011-2025. The accelerating earnings trend is +164.5% YoY. Historical data enables comparison across business cycles.